SCHEMBL12413918

SCHEMBL12413918

Cn1c(C(=O)O)c(-n2c(=O)[nH]c3ccccc3c2=O)c2ccc(Br)cc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNB2 O95067 1/20 0.53
▸ CDK1 P06493 1/20 0.53
▸ CCNB1 P14635 1/20 0.53
▸ CCNB3 Q8WWL7 1/20 0.53
▸ NPEPPS P55786 2/20 0.48
▸ ADORA3 P0DMS8 1/20 0.45
▸ ADORA2A P29274 1/20 0.45
▸ ADORA2B P29275 1/20 0.45
▸ ADORA1 P30542 1/20 0.45
▸ KDM4E B2RXH2 4/20 0.41
▸ GAA P10253 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ EGLN1 Q9GZT9 2/20 0.41
▸ TP53 P04637 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ HTT P42858 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12414420 0.91 NPEPPS (0.48) CCNB2CDK1CCNB1CCNB3NPEPPS
SCHEMBL12414426 0.83 NPEPPS (0.48) NPEPPSADORA3ADORA2AADORA2BADORA1
SCHEMBL12506791 0.82 NPEPPS (0.47) CCNB2CDK1CCNB1CCNB3NPEPPS
SCHEMBL12413945 0.82 KDM4E (0.52) NPEPPSADORA3ADORA2AADORA2BADORA1
SCHEMBL15849996 0.80 NPEPPS (0.46) CCNB2CDK1CCNB1CCNB3NPEPPS
SCHEMBL12414622 0.80 NPEPPS (0.46) CCNB2CDK1CCNB1CCNB3NPEPPS
SCHEMBL12506867 0.79 HSP90AA1 (0.49) CCNB2CDK1CCNB1CCNB3NPEPPS
SCHEMBL15849992 0.79 KDM4E (0.49) NPEPPSADORA3ADORA2AADORA2BADORA1
SCHEMBL12414430 0.79 MAPT (0.47) NPEPPSALDH1A1SMN1; SMN2PKMCA12
SCHEMBL12505237 0.78 NPEPPS (0.43) CCNB2CDK1CCNB1CCNB3NPEPPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765757-B2 3-heterocyclic substituted indole derivatives and methods of use thereof MERCK SHARP & DOHME CORP. (US) 2014-07-01 — — US disclosed
US-8765757-B2 3-heterocyclic substituted indole derivatives and methods of use thereof MERCK SHARP & DOHME CORP. (US) 2014-07-01 — — US disclosed
US-20110165118-A1 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF SCHERING CORPORATION 2011-07-07 — — US disclosed
US-20110165118-A1 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF SCHERING CORPORATION 2011-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165118-A1 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF IDO1, IDO2, HTR3C CCNB2 2279/4885CDK1 1569/4885CCNB1 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback